Literature DB >> 12076027

Gastrointestinal transit survival of an Enterococcus faecium probiotic strain administered with or without vancomycin.

Bodil Lund1, Inger Adamsson, Charlotta Edlund.   

Abstract

The primary aim of this study was to evaluate if an ingested probiotic, containing viable Enterococcus faecium could survive gastrointestinal transit and if so, correlate the amount of the recovered probiotic strain with the host's own enterococci. The second aim was to investigate if simultaneous vancomycin intake influenced the survival and persistence of the probiotic strain and the stability of endogenous enterococci strains. Twenty healthy volunteers were given the probiotic product once daily for 10 days. Half of the subjects were simultaneously given vancomycin. Isolates of E. faecium strains were genotypically or phenotypically analysed with pulsed-field gel electrophoresis (PFGE) and the PhenePlate system, respectively. In eight of the ten volunteers given only the probiotic, the ingested E. faecium could be detected on day 10, while in none on day 31. From subjects given both probiotic and vancomycin no ingested E. faecium could be detected on day 10 or day 31. The estimated amount of ingested E. faecium recovered from faeces on day 10 ranged from 1.2 x 10(3) to 4.2 x 10(6) colony forming units per gram faeces, which in several cases were a substantial part of the total amount of E. faecium. The E. faecium isolated before probiotic plus vancomycin administration showed no close relationship to the ones isolated 3 weeks after ceased intake in any subjects. In conclusion, the ingested E. faecium strain can survive gastrointestinal transit. After intake, the E. faecium probiotic strain might become a large part of the total E. faecium population. The occurrence of the probiotic strain in the human gut seems to be transient after intake stop. Re-colonization of E. faecium after simultaneous probiotic plus vancomycin intake occurs mainly with strains without close genetic relationship to the strains harboured before treatment or to the ingested E. faecium strain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12076027     DOI: 10.1016/s0168-1605(02)00047-8

Source DB:  PubMed          Journal:  Int J Food Microbiol        ISSN: 0168-1605            Impact factor:   5.277


  6 in total

1.  Frequent transmission of enterococcal strains between mechanically ventilated patients treated at an intensive care unit.

Authors:  Bodil Lund; Christina Agvald-Ohman; Anna Hultberg; Charlotta Edlund
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

2.  In vivo transfer of the vanA resistance gene from an Enterococcus faecium isolate of animal origin to an E. faecium isolate of human origin in the intestines of human volunteers.

Authors:  Camilla H Lester; Niels Frimodt-Møller; Thomas Lund Sørensen; Dominique L Monnet; Anette M Hammerum
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

Review 3.  A review of the advancements in probiotic delivery: Conventional vs. non-conventional formulations for intestinal flora supplementation.

Authors:  Mershen Govender; Yahya E Choonara; Pradeep Kumar; Lisa C du Toit; Sandy van Vuuren; Viness Pillay
Journal:  AAPS PharmSciTech       Date:  2013-09-25       Impact factor: 3.246

4.  A Dual-Biotic System for the Concurrent Delivery of Antibiotics and Probiotics: In Vitro, Ex Vivo, In Vivo and In Silico Evaluation and Correlation.

Authors:  Mershen Govender; Yahya E Choonara; Sandy van Vuuren; Pradeep Kumar; Lisa C du Toit; Kennedy Erlwanger; Viness Pillay
Journal:  Pharm Res       Date:  2016-09-06       Impact factor: 4.200

5.  Bloodstream isolates of Enterococcus faecium enriched with the enterococcal surface protein gene, esp, show increased adhesion to eukaryotic cells.

Authors:  Bodil Lund; Charlotta Edlund
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

6.  Effect of ingestion of soy yogurt on intestinal parameters of rats fed on a beef-based animal diet.

Authors:  Raquel Bedani; Nadiége Dourado Pauly-Silveira; Veridiana Soares Pereira Cano; Sandro Roberto Valentini; Graciela Font de Rossi; Elizeu Antonio Valdez
Journal:  Braz J Microbiol       Date:  2011-09-01       Impact factor: 2.476

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.